Explore

Rapid Read Rapid Read
HHS Secretary Kennedy Announces Plan to Reduce Psychiatric Drug Prescriptions

HHS Secretary Kennedy Announces Plan to Reduce Psychiatric Drug Prescriptions

Health and Human Services Secretary Robert F. Kennedy Jr. has unveiled a new action plan aimed at reducing psychiatric drug prescriptions. The plan, announced at a MAHA-aligned event, focuses on increasing education and training, promoting alternative treatment options, and reducing paperwork. Kennedy emphasized the goal of reducing unnecessary medication dependence and improving patient outcomes. The initiative aligns with the Make America Healthy Again movement, which advocates for informed consent and reduced overmedicalization in mental health. The plan encourages healthcare providers to consider non-medication treatment options and includes measures to support deprescribing practices.
Reuters Reuters
Warned off vaccine actions, Kennedy seeks quick health wins ahead of midterms

Warned off vaccine actions, Kennedy seeks quick health wins ahead of midterms

By Yasmeen Abutaleb and Bo Erickson WASHINGTON, May 4 (Reuters) - U.S. Health Secretary Robert F.
Rapid Read Rapid Read
Visa Delays Threaten Healthcare in Underserved U.S. Areas

Visa Delays Threaten Healthcare in Underserved U.S. Areas

The Department of Health and Human Services' visa waiver program, which allows foreign doctors to work in underserved U.S. areas, is experiencing significant delays. Hundreds of physicians awaiting J-1 visa waivers may have to leave the country if their applications are not processed by July 30. This backlog is causing concern among healthcare providers, as these doctors are crucial for serving vulnerable populations. The delays coincide with a new $100,000 fee for H-1B visas, which many hospitals cannot afford, further complicating the situation.
Rapid Read Rapid Read
Legal Challenge to CMS Hemp Strategy Raises Concerns Over FDA Authority

Legal Challenge to CMS Hemp Strategy Raises Concerns Over FDA Authority

A federal lawsuit in the U.S. District Court for the District of Columbia is challenging the legality of the Centers for Medicare & Medicaid Services' (CMS) Beneficiary Engagement Incentive (BEI) model. This program allows the furnishing of certain hemp-derived cannabinoid products to Medicare beneficiaries without U.S. Food and Drug Administration (FDA) approval. The case, Smart Approaches to Marijuana (SAM) et al. v. Robert F. Kennedy Jr. et al., questions whether CMS can introduce cannabinoid products into Medicare-connected environments without the traditional FDA approval process. Critics argue that this policy shift undermines the established sequence of science, clinical trials, FDA approval, and coverage integration, potentially signaling that clinical evidence is optional.
Trendline Trendline
Mapi Pharma Plans U.S. Aseptic Manufacturing Facility to Meet Growing Demand for Injectables

Mapi Pharma Plans U.S. Aseptic Manufacturing Facility to Meet Growing Demand for Injectables

Mapi Pharma Plans U.S. Aseptic Manufacturing Facility to Meet Growing Demand for Injectables
AP News AP News
Five Things to Know About Largest Cell Phone Ban Study

Five Things to Know About Largest Cell Phone Ban Study

A large study on school cell phone bans has found mixed results
Reuters Reuters
Meta to expand teen safeguards to 27 EU countries, Facebook safeguards in June

Meta to expand teen safeguards to 27 EU countries, Facebook safeguards in June

(Fixes typographical error in headline) By Foo Yun Chee BRUSSELS, May 5 (Reuters) - Meta Platforms will expand technology safeguards for teen accounts to 27 European Union countries and to Facebook in the United States, the U.S. tech giant said on Tuesday, as it seeks to fend off criticism regarding
AP News AP News
The Presidential Physical Fitness Award is back as Trump revives annual fitness test in US schools

The Presidential Physical Fitness Award is back as Trump revives annual fitness test in US schools

President Donald Trump is reviving the Presidential Physical Fitness Award as he reintroduces a competitive physical fitness test in America's schools
Trendline Trendline
Takeda's TAK-881 Shows Promising Results in Phase 2/3 Trial for Primary Immunodeficiency Disease

Takeda's TAK-881 Shows Promising Results in Phase 2/3 Trial for Primary Immunodeficiency Disease

Takeda's TAK-881 Shows Promising Results in Phase 2/3 Trial for Primary Immunodeficiency Disease
Trendline Trendline
FDA Approves Lannett's LANGLARA as Interchangeable Biosimilar for Diabetes Treatment

FDA Approves Lannett's LANGLARA as Interchangeable Biosimilar for Diabetes Treatment

FDA Approves Lannett's LANGLARA as Interchangeable Biosimilar for Diabetes Treatment
Reuters Reuters
Use of Gilead's HIV prevention shot rises, but US insurance gaps remain

Use of Gilead's HIV prevention shot rises, but US insurance gaps remain

By Deena Beasley May 5 (Reuters) - Use of Gilead Sciences' Yeztugo, a twice-yearly injection to prevent HIV infection, has climbed since its June launch, but U.S. health providers say not all patients are interested in the new option and those who want to try it can face insurance coverage gaps.
Reuters Reuters
UnitedHealthcare removes prior approval requirements for 30% of healthcare services

UnitedHealthcare removes prior approval requirements for 30% of healthcare services

May 5 (Reuters) - UnitedHealth will eliminate prior approval requirements for 30% of healthcare services, its insurance unit said on Tuesday, further reducing delays and paperwork for patients and doctors.